Log on / register
BioMed Central home | Journals A-Z | Feedback | Support
Open AccessHighly AccessReview

Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities

Cornel Pater email

Cornel Pater, Hannover, Germany

author email corresponding author email

Current Controlled Trials in Cardiovascular Medicine 2005, 6:1doi:10.1186/1468-6708-6-1

Published: 3 February 2005

First paragraph (this article has no abstract)

Assessment of the QT interval started to receive increased regulatory attention in the late 1980s.


© 1999-2008 BioMed Central Ltd unless otherwise stated < info@biomedcentral.com >   Terms and conditions